On January 31, 2017, the French National Drug and Health Product Agency ("ANSM") issued an updated FAQ related to the authorization and declaration procedures of manufacturing, import, and ...

Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has secured full regulatory clearance from France's National Agency for ...

Following extensive discussions, GenSight reached alignment with ANSM on a plan to open the LUMEVOQ ® AAC program. The agency has agreed that the authorization of a focused dose-ranging study could ...

The company’s state-of-the-art sterile drug product manufacturing site in Saint-Beauzire, France, opened in February 2023. Pharmaceutical process development and API manufacturing company CARBOGEN ...

France is currently working toward the eventual launch of its official medical cannabis program, and a new update from the French National Medicines Safety Agency (ANSM) recently announced that access ...

NANTES, France--(BUSINESS WIRE)--Regulatory News: Pherecydes Pharma (Paris:ALPHE) (FR0011651694 - ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or ...

The French National Agency for the Safety of Medicines and Health Products (ANSM) has authorised FineHeart to commence a nonrandomised first-in-human trial in the country to assess the FlowMaker ...

PARIS – The French National Agency for the Safety of Medicinal and Healthcare Products (ANSM), has published its latest annual report on the drugs and medical devices market in France. This body, ...

Recipharm Monts has announced that it has secured authorization from the French health authorities (ANSM) to fill biotech products. Consequently, Recipharm is able to expand and diversify its combined ...

NANTES, France--(BUSINESS WIRE)--Regulatory News: Pherecydes Pharma (FR0011651694 – ALPHE) (Paris:ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or ...